1. Jansen K, Shaw A. HPV clinical problems. Ann Rev Med. 2004;55:319-331.
2. Aleksandrova GA, Kubanov AA, Melekhina LE, Bogdanova EV, Lebedev GS, Ogryzko EV, Fomin VN, Kanteeva AN, Avdeeva LN. Statisticheskie materialy: Zabolevaemost', resursy i deyatelnost' kozhno-venerologicheskikh uchrezhdenii. [Statistical materials: Morbidity, resources and activities of dermal and venereological institutions]. M. 2013;119. (In Russ.).
3. Dunne E. Strategies to monitor HPV vaccine impact in US. Abstracts. 25 HPV conference. Sweden. 2009.
4. Dillner J. Results of HPV vaccine study in Sweeden. Abstracts. 25 HPV conference Sweeden. 2009.
5. Koutsky L. Monovalent HPV 16 vaccine. Am J Med. 1997;102:3-8.